Synthetic oligopeptide substrates: their diagnostic application in blood coagulation, fibrinolysis, and other pathologic states.
D000686:Amyloidosis / Q000175:diagnosis; D000818:Animals; D001161:Arteriosclerosis / Q000175:diagnosis; D001172:Arthritis, Rheumatoid / Q000175:diagnosis; D001778:Blood Coagulation Disorders / Q000175:diagnosis*; D001779:Blood Coagulation Factors / Q000378:metabolism; D002918:Chymotrypsin / Q000378:metabolism; D002919:Chymotrypsinogen / Q000378:metabolism; D003920:Diabetes Mellitus / Q000175:diagnosis; D004646:Emphysema / Q000175:diagnosis; D005342:Fibrinolysis; D005767:Gastrointestinal Diseases / Q000175:diagnosis; D006801:Humans; D007610:Kallikreins / Q000378:metabolism; D007674:Kidney Diseases / Q000175:diagnosis; D009136:Muscular Dystrophies / Q000175:diagnosis; D009842:Oligopeptides / Q000138:chemical synthesis; D010447:Peptide Hydrolases / Q000378:metabolism; D013379:Substrate Specificity; D013552:Swine / Q000502:physiology
D001779:Blood Coagulation Factors; D009842:Oligopeptides; D002919:Chymotrypsinogen; D010447:Peptide Hydrolases; D007610:Kallikreins; D002918:Chymotrypsin